Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Giordano

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|July 27, 2024
Immunotherapy in Breast CancerKathrin Dvir, Sara Giordano, Jose Pablo Leone
Neuropsychiatric Disease and Treatment|August 17, 2013
Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustmentFelice Iasevoli, Raffaele Balletta, Valentina Gilardi, et al.
NPJ Breast Cancer|July 30, 2025
Antibody-drug conjugates for treating early-stage breast cancer: current use, anticipated evolutionsPooja Patel, Antonio Giordano, Sara Giordano, et al.
Psychiatry Research|August 6, 2013
Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics dosesAndrea de Bartolomeis, Raffaele Balletta, Sara Giordano, et al.
Journal of Adolescent and Young Adult Oncology|August 12, 2016
Association of BRCA1 Mutations with Impaired Ovarian Reserve: Connection Between Infertility and Breast/Ovarian Cancer RiskSara Giordano, Elizabeth Garrett-Mayer, Navdha Mittal, et al.
Psychiatry Research|January 21, 2017
Assessing patient-rated vs. clinician-rated adherence to the therapy in treatment resistant schizophrenia, schizophrenia responders, and non-schizophrenia patientsFelice Iasevoli, Andrea Fagiolini, Maria Vittoria Formato, et al.
Schizophrenia Research|June 24, 2018
Clinical evaluation of functional capacity in treatment resistant schizophrenia patients: Comparison and differences with non-resistant schizophrenia patientsFelice Iasevoli, Luigi D'Ambrosio, Danilo Notar Francesco, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 31, 2015
Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestonesFelice Iasevoli, Sara Giordano, Raffaele Balletta, et al.
Rivista Di Psichiatria|March 2, 2018
[From OPG to REMS: the role of a territorial health service in the implementation of security and non-custodial measures towards offenders with psychological problems]Gianmarco Latte, Livia Avvisati, Sara Calandro, et al.
JCO Oncology Practice|December 19, 2022
Training Hematologists/Oncologists for the Academic-Community Hybrid: Creating a Fellowship Framework for the FutureDaniel A Roberts, Jennifer Faig, Kelly Bodio-Downey, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|July 27, 2024
Immunotherapy in Breast CancerKathrin Dvir, Sara Giordano, Jose Pablo Leone
Neuropsychiatric Disease and Treatment|August 17, 2013
Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustmentFelice Iasevoli, Raffaele Balletta, Valentina Gilardi, et al.
NPJ Breast Cancer|July 30, 2025
Antibody-drug conjugates for treating early-stage breast cancer: current use, anticipated evolutionsPooja Patel, Antonio Giordano, Sara Giordano, et al.
Psychiatry Research|August 6, 2013
Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics dosesAndrea de Bartolomeis, Raffaele Balletta, Sara Giordano, et al.
Journal of Adolescent and Young Adult Oncology|August 12, 2016
Association of BRCA1 Mutations with Impaired Ovarian Reserve: Connection Between Infertility and Breast/Ovarian Cancer RiskSara Giordano, Elizabeth Garrett-Mayer, Navdha Mittal, et al.
Psychiatry Research|January 21, 2017
Assessing patient-rated vs. clinician-rated adherence to the therapy in treatment resistant schizophrenia, schizophrenia responders, and non-schizophrenia patientsFelice Iasevoli, Andrea Fagiolini, Maria Vittoria Formato, et al.
Schizophrenia Research|June 24, 2018
Clinical evaluation of functional capacity in treatment resistant schizophrenia patients: Comparison and differences with non-resistant schizophrenia patientsFelice Iasevoli, Luigi D'Ambrosio, Danilo Notar Francesco, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 31, 2015
Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestonesFelice Iasevoli, Sara Giordano, Raffaele Balletta, et al.
Rivista Di Psichiatria|March 2, 2018
[From OPG to REMS: the role of a territorial health service in the implementation of security and non-custodial measures towards offenders with psychological problems]Gianmarco Latte, Livia Avvisati, Sara Calandro, et al.
JCO Oncology Practice|December 19, 2022
Training Hematologists/Oncologists for the Academic-Community Hybrid: Creating a Fellowship Framework for the FutureDaniel A Roberts, Jennifer Faig, Kelly Bodio-Downey, et al.
Pageof 2